Artificial Intelligence-Enabled Predictive Model of Progression From Moderate to Severe Aortic Stenosis

BACKGROUND

Progression from moderate to severe aortic stenosis (AS) warrants careful monitoring due to the increased risk of sudden death and heart failure, with disease progression significantly varying among patients and no accurate predictive tools presently available.

OBJECTIVE

A Disease Progression Algorithm was developed from a deidentified database of 1,163,923 echocardiographic (echo) reports from 35 US institutions (egnite Database; egnite, Inc., Aliso Viejo, CA, USA) to predict the likelihood that a patient with moderate AS has progressed to severe AS over a 1- and 2-year period.

METHODS

Echocardiographic reports meeting inclusion criteria were ordered by patient and split into training (N = 4,499 patients) and test (N = 1,886 patients) datasets. Natural language processing and statistical modeling were used to support echocardiographic report evaluation and algorithm training, respectively. Algorithm development utilized a Cox proportional hazards model based on aortic valve (AV) measurements (AV area [AVA], jet velocity [JV], and mean pressure gradient [MPG]), age at date of index echocardiographic report, and time since moderate AS diagnosis to generate a predicted progression index (estimating the likelihood of a severe AS diagnosis upon reexamination with echo). Validation analyses compared population progression indexes to estimated actual observed disease progression towards severe AS within the test dataset.

RESULTS

Algorithm predictions approximated that 17.2% and 41.3% of the population would progress to severe AS at years 1 and 2, respectively, with the estimated actual observed progression of 15.8% and 42.0% at years 1 and 2, respectively. Progression for subpopulations stratified by initial AV measurements (AVA, JV, MPG) were predicted with an average error of 2.3% points.

CONCLUSIONS

Overall, the Disease Progression Algorithm represents a useful clinical tool that can accurately predict the progression from moderate to severe AS, identify subpopulations of patients who were more likely to progress to severe AS, and help physicians identify/prioritize patients who require careful follow-up after the diagnosis of moderate AS, potentially closer than recommended guidelines.

Moualla SK, McCarthy PM, Thomas JD, Dobbles M, Petrescu OM, Loper T, Barnhart GR, Brennan JM. Artificial intelligence-enabled predictive model of progression from moderate to severe aortic stenosis. Intelligence-Based Medicine. 2022;6:100062. doi: 10.1016/j.ibmed.2022.100062​​

*This study is part of egnite’s cardiovascular real-world evidence bibliography, which lists all of our peer-reviewed articles, conference abstracts, and patents.

Follow egnite on social:

Related Articles

Press

egnite’s Call for Science Study on M-TEER Device Durability and Long-Term Patient Outcomes to be Featured at TCT 2026

The egnite Registry contributed de-identified, longitudinal data, linking serial echocardiograms with clinical outcomes, to help answer what happens to patients after a successful mitral transcatheter edge-to-edge repair (M-TEER) procedure.  ALISO VIEJO, Calif. — October 13, 2026 — egnite, Inc., a cardiovascular intelligence company that helps clinicians identify and manage patients with untreated heart disease, today announced that Dr. John T. Saxon, Director of the Advanced Cardiac Valve Center at University of Virginia

Publications

Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From egnite Data

BACKGROUND Aortic stenosis (AS) and mitral regurgitation (MR) frequently co-occur, complicating diagnosis and treatment. We examined current US treatment trends and patient outcomes among patients with severe AS and at least moderate MR. METHODS We analyzed data from 2 992 362 patients (aged ≥18 years) undergoing 5 245 904 echocardiograms at 43 US institutions

"The future of aortic stenosis care requires proactive identification, longitudinal monitoring, and intentional pipeline management."
egnite Research

Rethinking the Aortic Stenosis Pipeline

Aortic stenosis care is shifting from a reactive to a proactive model. Emerging clinical evidence supports earlier identification, closer monitoring, and intentional patient management across the disease continuum. As treatment thresholds evolve, health systems need scalable approaches to identify at-risk patients, close treatment gaps, and ensure timely access to specialist care.